The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model

Non-steroidal anti-inflammatory drugs (NSAIDs) are some of the most widely used drugs due to their anti-inflammatory, analgesic and antipyretic pharmacological effects. Gastrointestinal side effects are some of the most severe and frequent side effects of NSAIDs. These depend on the balance of the g...

Full description

Bibliographic Details
Main Authors: Maria-Adriana Neag, Carmen-Stanca Melincovici, Adrian Catinean, Dana-Maria Muntean, Raluca-Maria Pop, Ioana-Corina Bocsan, Andrei-Otto Mitre, Mihai-Bogdan Cardos, Andreea-Ioana Inceu, Anca-Dana Buzoianu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/10/2508
_version_ 1827651400932261888
author Maria-Adriana Neag
Carmen-Stanca Melincovici
Adrian Catinean
Dana-Maria Muntean
Raluca-Maria Pop
Ioana-Corina Bocsan
Andrei-Otto Mitre
Mihai-Bogdan Cardos
Andreea-Ioana Inceu
Anca-Dana Buzoianu
author_facet Maria-Adriana Neag
Carmen-Stanca Melincovici
Adrian Catinean
Dana-Maria Muntean
Raluca-Maria Pop
Ioana-Corina Bocsan
Andrei-Otto Mitre
Mihai-Bogdan Cardos
Andreea-Ioana Inceu
Anca-Dana Buzoianu
author_sort Maria-Adriana Neag
collection DOAJ
description Non-steroidal anti-inflammatory drugs (NSAIDs) are some of the most widely used drugs due to their anti-inflammatory, analgesic and antipyretic pharmacological effects. Gastrointestinal side effects are some of the most severe and frequent side effects of NSAIDs. These depend on the balance of the gut microbiome, the abundance of Gram-negative bacteria, and the amount of lipopolysaccharide released. Therefore, restoring or improving gut bacteria balance with probiotic supplements could prove to be an adjuvant therapy against mild NSAID-induced enteropathy. Twenty-five Wistar albino male rats were divided into five groups. The negative control group was administered carboxymethylcellulose and the positive control group diclofenac (DIC), 8 mg/kg for 7 days, which represented the enteropathy model. Treatment groups consisted of a combination of pro-biotic spores (MSB), amino acids and immunoglobulins supplement (MM), which were also administered for 7 days. We analyzed hepatic injury markers (AST, ALT) and creatinine, and inflammatory markers, IL-6, TNF-α, PGE2, iNOS, as well as total antioxidant capacity. The results obtained in the present study suggest that the modulation of the intestinal microbiota by administration of probiotics (Bacillus spores), alone or in combination with immunoglobulins and amino acids, represents an attractive therapy for the prevention of NSAID-induced enteropathy.
first_indexed 2024-03-09T20:39:12Z
format Article
id doaj.art-af1ea7b8025c426a8b20f783f1a2018e
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T20:39:12Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-af1ea7b8025c426a8b20f783f1a2018e2023-11-23T23:04:12ZengMDPI AGBiomedicines2227-90592022-10-011010250810.3390/biomedicines10102508The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy ModelMaria-Adriana Neag0Carmen-Stanca Melincovici1Adrian Catinean2Dana-Maria Muntean3Raluca-Maria Pop4Ioana-Corina Bocsan5Andrei-Otto Mitre6Mihai-Bogdan Cardos7Andreea-Ioana Inceu8Anca-Dana Buzoianu9Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaHistology Discipline, Morphological Sciences Department, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, RomaniaDepartment of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Technology and Biopharmaceutics, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaFaculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, RomaniaEmergency Clinical County Hospital Cluj-Napoca, 400006 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaNon-steroidal anti-inflammatory drugs (NSAIDs) are some of the most widely used drugs due to their anti-inflammatory, analgesic and antipyretic pharmacological effects. Gastrointestinal side effects are some of the most severe and frequent side effects of NSAIDs. These depend on the balance of the gut microbiome, the abundance of Gram-negative bacteria, and the amount of lipopolysaccharide released. Therefore, restoring or improving gut bacteria balance with probiotic supplements could prove to be an adjuvant therapy against mild NSAID-induced enteropathy. Twenty-five Wistar albino male rats were divided into five groups. The negative control group was administered carboxymethylcellulose and the positive control group diclofenac (DIC), 8 mg/kg for 7 days, which represented the enteropathy model. Treatment groups consisted of a combination of pro-biotic spores (MSB), amino acids and immunoglobulins supplement (MM), which were also administered for 7 days. We analyzed hepatic injury markers (AST, ALT) and creatinine, and inflammatory markers, IL-6, TNF-α, PGE2, iNOS, as well as total antioxidant capacity. The results obtained in the present study suggest that the modulation of the intestinal microbiota by administration of probiotics (Bacillus spores), alone or in combination with immunoglobulins and amino acids, represents an attractive therapy for the prevention of NSAID-induced enteropathy.https://www.mdpi.com/2227-9059/10/10/2508NSAIDsprobioticsenteropathyinflammationmicrobiota
spellingShingle Maria-Adriana Neag
Carmen-Stanca Melincovici
Adrian Catinean
Dana-Maria Muntean
Raluca-Maria Pop
Ioana-Corina Bocsan
Andrei-Otto Mitre
Mihai-Bogdan Cardos
Andreea-Ioana Inceu
Anca-Dana Buzoianu
The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
Biomedicines
NSAIDs
probiotics
enteropathy
inflammation
microbiota
title The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
title_full The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
title_fullStr The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
title_full_unstemmed The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
title_short The Role of Probiotic Bacillus Spores and Amino Acids with Immunoglobulins on a Rat Enteropathy Model
title_sort role of probiotic bacillus spores and amino acids with immunoglobulins on a rat enteropathy model
topic NSAIDs
probiotics
enteropathy
inflammation
microbiota
url https://www.mdpi.com/2227-9059/10/10/2508
work_keys_str_mv AT mariaadriananeag theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT carmenstancamelincovici theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT adriancatinean theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT danamariamuntean theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ralucamariapop theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ioanacorinabocsan theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT andreiottomitre theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT mihaibogdancardos theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT andreeaioanainceu theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ancadanabuzoianu theroleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT mariaadriananeag roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT carmenstancamelincovici roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT adriancatinean roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT danamariamuntean roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ralucamariapop roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ioanacorinabocsan roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT andreiottomitre roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT mihaibogdancardos roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT andreeaioanainceu roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel
AT ancadanabuzoianu roleofprobioticbacillussporesandaminoacidswithimmunoglobulinsonaratenteropathymodel